Home
About
Overview
Sharing Data
ORCID
Help
History (10)
On Bayesian calculations for mixture likelihoods and priors.
Nation Building and Social Signaling in Southern Ontario: A.D. 1350-1650.
John Roderick Cameron (1922-2005): Scientist, teacher, mentor, inventor, and philanthropist extraordinaire.
Improving access to neurodevelopmental resources for NICU graduates.
Zhang, Zhuzhu
See All 10 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Garassino, Marina Chiara
One or more keywords matched the following items that are connected to
Garassino, Marina Chiara
Item Type
Name
Concept
Survival Rate
Academic Article
DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation.
Academic Article
Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program.
Academic Article
Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy.
Academic Article
Clinical and molecular determinants of survival in pancreatic cancer patients treated with second-line chemotherapy: results of an Italian/Swiss multicenter survey.
Academic Article
Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer.
Academic Article
Value of KRAS as prognostic or predictive marker in NSCLC: results from the TAILOR trial.
Academic Article
The impact of personalized medicine on survival: comparisons of results in metastatic breast, colorectal and non-small-cell lung cancers.
Academic Article
Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer.
Academic Article
Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis.
Academic Article
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis.
Academic Article
Second-line chemotherapy in malignant pleural mesothelioma: results of a retrospective multicenter survey.
Academic Article
Outpatient palliative care and thoracic medical oncology: Referral criteria and clinical care pathways.
Academic Article
Mesothelioma and thymic tumors: Treatment challenges in (outside) a network setting.
Academic Article
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA.
Academic Article
Relationship Between Programmed Death Receptor-Ligand 1 Expression and Response to Checkpoint Inhibitor Immunotherapy in Pulmonary Sarcomatoid Carcinoma: A Pooled Analysis.
Academic Article
Treatment patterns among patients with malignant pleural mesothelioma: An Italian, population-based nationwide study.
Academic Article
Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutations.
Academic Article
Does surgery improve survival of patients with malignant pleural mesothelioma?: a multicenter retrospective analysis of 1365 consecutive patients.
Academic Article
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Academic Article
Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.
Academic Article
Poziotinib in Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutations After Prior Therapies: ZENITH20-2 Trial.
Search Criteria
Survival Rate